Frontlight ResearchEarly access
Trial site
Showa Medical University Hospital
- 6running trials
- 1closed trial
The trials here
What the 7 trials at this site are about, from their registry records.
- Conditions
- Coronary artery disease2 trials
- Triple-negative breast cancer2 trials
- Gastric and oesophageal cancer1 trial
- IgA nephropathy1 trial
- Lung cancer1 trial
- Metastatic breast cancer1 trial
- Phase
- Phase 32 trials
- Phase 11 trial
- Phase 1/21 trial
- Phase 21 trial
- Status
- Recruiting3 trials
- Active, not recruiting2 trials
- Completed1 trial
- Not yet recruiting1 trial
- Lead sponsor
- Daiichi Sankyo2 trials
- Abbott Medical Devices1 trial
- Biogen1 trial
- Boston Scientific Corporation1 trial
- Daiichi Sankyo Co., Ltd.1 trial
- and 1 more
Running trials
Recruiting
Active, not recruiting
Recruiting
Pembrolizumab + Paclitaxel +/- Bevacizumab for Triple-negative Breast Cancer
Recruiting
Recruiting
Active, not recruiting
First-in-human Study of DS-1062a for Advanced Solid Tumors (TROPION-PanTumor01)
Recruiting at the same time
How many trials recruit for the same indication here at once. A count, not a rating.
- Gastric and oesophageal cancer1 recruiting
- IgA nephropathy1 recruiting
- Metastatic breast cancer1 recruiting
- Triple-negative breast cancer1 recruiting
Closed trials
Site data: ClinicalTrials.govUpdated 12 Nov 2026